United States - English - NLM (National Library of Medicine)

true botanica, llc - strontium sulfate (unii: 7q3kx2l47f) (strontium - unii:yzs2rpe8le) - for temporary relief of weak ligaments, nervous tics. may also be used for standard homeopathic indications or as directed by your physician. supports healthy bone structure. for temporary relief of anxiety, unexplained fears. may also be used for standard homeopathic indications or as directed by your physician. tamper evident: do not use if safety seal is broken before first use.

Canada - English - Health Canada

homeocan inc. - strontium nitrate sr 85 - tablet - 6ch - strontium nitrate sr 85 6ch - homeopathic products

Canada - English - Health Canada

homeocan inc. - strontium carbonate - tablet - 6ch - strontium carbonate 6ch - homeopathic products

Canada - English - Health Canada

biologische heilmittel heel gmbh - strontium carbonate - liquid - 12d - strontium carbonate 12d - homeopathic products

Canada - English - Health Canada

biologische heilmittel heel gmbh - strontium carbonate - liquid - 6d - strontium carbonate 6d - homeopathic products

Canada - English - Health Canada

total health centre - strontium carbonate - drops - 6x - strontium carbonate 6x - homeopathic products

Canada - English - Health Canada

dolisos canada inc. - strontium carbonate - globules - 6x - strontium carbonate 6x - homeopathic products

United States - English - NLM (National Library of Medicine)

parapro llc - esomeprazole strontium (unii: c5n25h3803) (esomeprazole - unii:n3pa6559ft) - esomeprazole 24.65 mg - 1.1 treatment of gastroesophageal reflux disease (gerd) in adults healing of erosive esophagitis esomeprazole strontium is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole strontium may be considered. maintenance of healing of erosive esophagitis esomeprazole strontium is indicated to maintain symptom resolution and healing of erosive esophagitis. controlled studies do not extend beyond 6 months. symptomatic gastroesophageal reflux disease esomeprazole strontium is indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults. 1.2 risk reduction of nsaid-associated gastric ulcer in adults esomeprazole strontium is indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy in patients at risk for devel

United States - English - NLM (National Library of Medicine)

r2 pharma, llc - esomeprazole strontium (unii: c5n25h3803) (esomeprazole - unii:n3pa6559ft) - esomeprazole 40 mg - 1.1 treatment of gastroesophageal reflux disease (gerd) in adults healing of erosive esophagitis esomeprazole strontium is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole strontium may be considered. maintenance of healing of erosive esophagitis esomeprazole strontium is indicated to maintain symptom resolution and healing of erosive esophagitis. controlled studies do not extend beyond 6 months. symptomatic gastroesophageal reflux disease esomeprazole strontium is indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults. 1.2 risk reduction of nsaid-associated gastric ulcer in adults esomeprazole strontium is indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy in patients at risk for devel

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - strontium(89sr) chloride, quantity: 37 mbq/ml - injection, solution - excipient ingredients: strontium chloride; water for injections - indications as at 20 may 2005 : for the palliation of pain from sclerotic bone metastases secondary to prostate carcinoma in patients who have not responded, or who are no longer responding to conventional therapies, including external beam radiotherapy. as an alternative to external beam therapy for the palliation of pain from bone metastases secondary to prostatic carcinoma at the stage of hormone therapy failure.